Bovatec has been shown to control the effects of coccidiosis and reduce the potential for its transmission, meaning treated calves are more likely to reach their full growth and production potential1.
Bovatec formulations are designed to meet your calves’ needs at each life stage:
- Bovatec® is added to leading fortified calf milk additives or calf milk replacers to prevent coccidiosis, making it ideal for pre-weaned calves.
- Bovatec® 20CC is mixed with calf and heifer pellets to reduce the risk of coccidiosis, and to promote growth, liveweight gain and feed conversion in calves.
Bovatec promotes both feed consumption and growth
Bovatec in combination with appropriate roughage promotes optimal rumen development which is vital for healthy growth in both calves and heifers. Furthermore, research has shown that when Bovatec is added to grain supplement, cattle achieve higher daily growth rates2. Calves have been shown to eat significantly more of a ration containing Bovatec than sodium monensin3.
This can lead to earlier heifers conceiving and calving earlier, resulting in:
Increased first lactation and lifetime milk production
Less culling due to failure to conceive or poor production
Fewer replacement heifers required
Maximised genetic potential
Bovatec also has a 2–5 times greater safety margin in calves than monensin4, giving you peace of mind.
1. Heinrichs AJ & Bush GJ. (1991). Our Industry Today. Evaluation of Decoquinate or Lasalocid Against Coccidiosis from Natural Exposure in Neonatal Dairy Calves. Journal of Dairy Science. 74(9): 3223–3227.
2. Stephen Page (2003). The role of enteric antibiotics in livestock production. A review of published literature prepared for Avcare. Canberra ACT: Avcare Advanced Veterinary Therapeutics.
3. Nussio et al (2002). Decoquinate, lasalocid and monesin for starter feeds and the performance of holstein calves to 20 weeks of age. Scientia Agricola. 59(3):421–426.
4. Blanchard PC et al, (1993). Lasalocid toxicosis in dairy calves. J Vet Diagn Invest 5:300–302.